INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 304 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $924,291 | -24.4% | 40,274 | -29.7% | 0.00% | -100.0% |
| Q1 2024 | $1,222,233 | -26.2% | 57,328 | +1.5% | 0.00% | 0.0% |
| Q4 2023 | $1,655,120 | -15.9% | 56,508 | -14.3% | 0.00% | 0.0% |
| Q3 2023 | $1,968,005 | +7.2% | 65,974 | +46.4% | 0.00% | 0.0% |
| Q2 2023 | $1,835,084 | +188.3% | 45,077 | +153.5% | 0.00% | – |
| Q1 2023 | $636,453 | +0.2% | 17,783 | +5.0% | 0.00% | – |
| Q4 2022 | $635,269 | -55.5% | 16,936 | -27.7% | 0.00% | -100.0% |
| Q3 2022 | $1,427,000 | +110.8% | 23,426 | +120.9% | 0.00% | 0.0% |
| Q2 2022 | $677,000 | +74.5% | 10,607 | +80.2% | 0.00% | – |
| Q1 2022 | $388,000 | +103.1% | 5,887 | +175.5% | 0.00% | – |
| Q4 2021 | $191,000 | -23.0% | 2,137 | +15.8% | 0.00% | – |
| Q3 2021 | $248,000 | – | 1,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 1,859,926 | $301,141,000 | 48.58% |
| Burrage Capital Management LLC | 63,634 | $10,303,000 | 10.33% |
| Elmwood Wealth Management, Inc. | 67,174 | $10,876,000 | 5.73% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 300,327 | $48,626,000 | 4.72% |
| Discovery Value Fund | 929,669 | $150,523,000 | 4.08% |
| Ikarian Capital, LLC | 294,400 | $47,667,000 | 3.85% |
| Ally Bridge Group (NY) LLC | 93,127 | $15,078,000 | 3.75% |
| GREAT POINT PARTNERS LLC | 100,000 | $16,191,000 | 3.40% |
| ARK Investment Management | 7,684,441 | $1,244,188,000 | 2.32% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $18,043,000 | 2.30% |